Results 171 to 180 of about 41,565 (267)

Relapsing-Remitting Multiple Sclerosis [PDF]

, 2012
openaire   +1 more source

Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review. [PDF]

J Neurol
Avedillo-Salas A, Martínez LB, Fanlo-Villacampa A, Vicente-Romero J.   +3 more
europepmc   +1 more source

The role of fear of relapse in quality of life among patients with relapsing-remitting multiple sclerosis. [PDF]

Front Neurol
Öztürk P, Öztürk M.
europepmc   +1 more source

Health-Related Quality of Life in Radiologically Isolated Syndrome Resembles Relapsing-Remitting Multiple Sclerosis. [PDF]

J Clin Med
Benito-León J, Díez-Cirarda M, Ruiz-Ortiz M, Aladro Y, Cuevas C, Domingo-Santos Á, Galán Sánchez-Seco V, Labiano-Fontcuberta A, Gómez-López A, Salgado-Cámara P, Costa-Frossard L, Monreal E, Sainz de la Maza S, Matías-Guiu J, Montero-Escribano P, Martínez-Ginés ML, Ayuso-Peralta L, Matías-Guiu JA.   +17 more
europepmc   +1 more source

Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis. [PDF]

Front Immunol
Buhelt S, Hansen MB, Søndergaard HB, El Mahdaoui S, Hansen MM, Mahler MR, Romme Christensen J, Sellebjerg F.   +7 more
europepmc   +1 more source

Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disability. [PDF]

Mult Scler J Exp Transl Clin
Pérez-Sempere Á, García-Arcelay E, Caruncho J, Candeliere-Merlicco A, Orviz A, Martín-Martínez J, Morales RP, Álvarez-Rodríguez E, Pacheco EM, Borrega L, Casanova I, Caminero AB, Sánchez-Menoyo JL, Gómez-Gutiérrez M, Carmona O, Calles C, Hernández MA, López-Muñoz P, González-Suárez I, Joly H, Maurino J.   +20 more
europepmc   +1 more source

The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis. [PDF]

J Neuroinflammation
Marastoni D, Eccher C, Signori A, Anni D, Foschi M, Crescenzo F, Mazziotti V, Virla F, Sicchieri M, Turano E, Tamanti A, Camera V, Ziccardi S, Zanetti G, Pizzini FB, Martini S, Fratucello A, Bonetti B, Sormani MP, Calabrese M.   +19 more
europepmc   +1 more source

Immunogenicity of Hepatitis B Virus Vaccination in Relapsing-Remitting Multiple Sclerosis Patients Under Immunocompromising Treatment. [PDF]

Int J Mol Sci
Cruces-Párraga J, Muñoz-Jurado A, Escribano BM, Martín-Hersog FA, Triguero-Ortiz C, Carmona-Medialdea C, Túnez I, Caballero-Villarraso J, Agüera-Morales E.   +8 more
europepmc   +1 more source

Relapsing-Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome. [PDF]

Ann Clin Transl Neurol
Ganesan SM, Yadav M, Ghimire S, Lehman PC, Patel AJ, Woods S, Olalde H, Hoang J, Paullus M, Cherwin C, Gill C, Cho T, Mangalam AK.   +12 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study. [PDF]

Eur J Neurol
Savolainen M, Soilu-Hänninen M, Nurmi H, Viitala M, Tienari P, Atula S, Laakso SM.   +6 more
europepmc   +1 more source